AstronauTx completes £48M funding for new Alzheimer's Disease therapies 09-Oct-2023 By Liza Laws Biotech company, AstronauTx Ltd yesterday (October 9) announced the completion of a £48 million ($61 million) Series A financing.
Nanopharmaceutics recruits PrecisionLife to accelerate CNS pipeline 27-Jun-2023 By Jonathan Smith The US drug developer Nanopharmaceutics has teamed up with PrecisionLife in a strategic collaboration to accelerate the development of Nanopharmaceutics’ central nervous system (CNS) drug pipeline with precision medicine.